Keio University has registered UMIN000058083, an interventional study examining hydrogen-gas inhalation during exercise in healthy adults. The public UMIN Clinical Trials Registry record describes an investigation of the “anti-fatigue effect” of hydrogen-gas inhalation during exercise. That language names a research objective, not an established result.
The clinical-trial registry is useful because it lets readers see the question before any headline is written around it. In the Hydrogen Wellness Industry, that is a meaningful distinction: a study protocol can be a credible starting point for inquiry while still being far from a consumer-facing conclusion.
What the public record specifies
The record describes a randomized, single-blind, two-arm crossover study. Participants complete 30 minutes of constant-load exercise under a hydrogen-inhalation condition and a condition without hydrogen inhalation. The planned sample size is 36 healthy adults aged 18 to 60 who can continue moderate-intensity exercise for 30 minutes.
Maximum oxygen intake during exercise is listed as the primary outcome. Secondary measurements include heart rate, blood lactate, oxygen intake, thigh-muscle oxygen saturation, perceived exertion, standing-exercise heart-rate variability, salivary IgA, and blood proteomics. Together, these fields show an exercise-physiology and exploratory-biomarker framework rather than a general consumer-wellness assessment.
Why this is useful beyond the study itself
For industry readers, the case illustrates what a more legible research conversation looks like. A claim about exercise or recovery should lead back to a defined intervention, population, comparator, duration, endpoint, and result status. Without those fields, a marketing phrase is difficult to interpret or compare.
- Protocol before promise: study design makes an intended comparison visible.
- Measurement before shorthand: physiological and biomarker measures are not interchangeable with a broad “energy” or “recovery” claim.
- Status before storytelling: readers need to know whether outcomes have actually been published.
What the registry does not establish
The registry states that recruitment is no longer ongoing and marks results as unpublished. It does not establish that hydrogen inhalation reduces fatigue, improves exercise performance or recovery, is safe for any population, or has regulatory approval for a health indication.
The record lists Keio University School of Medicine’s Institute for Integrated Sports Medicine as the sponsoring institution and Kotobiken Medical Laboratories, Inc. as the funding source. That disclosure is useful context; it does not remove the need for a complete report of methods, outcomes, adverse events, and conflicts when results become available.
Questions worth following
- Will the investigators publish prespecified primary and secondary outcome data with crossover-period handling and statistical details?
- Will future reporting specify concentration, delivery verification, adherence, adverse events, and protocol deviations?
- How will the study separate an inhalation condition from exercise adaptation, expectation, and period effects?
UMIN Clinical Trials Registry: UMIN000058083
Source type: public clinical-trial registry. The registry is linked for verification of protocol fields and status. This H2 Wellness Hub article is an independent industry reading and does not report a study result.
Open the UMIN registry record ↗